Cross-Disease Transcriptomic Analysis Identifies Selective Lysosomal Gene-Expression Patterns in Alzheimer’s Disease and Lung Cancer
Alzheimer’s disease (AD) and lung cancer show an inverse transcriptomic relationship, but how this genome-wide pattern is organized within the lysosomal system remains unclear. To address this question, a staged analysis combined the Sánchez-Valle primary bulk dataset, a Forés-Martos cross-study reproducibility assessment, a harmonized 73-gene lysosomal panel organized into seven functional modules, AD single-nucleus data, and matched lung cancer and AD myeloid resources. In Sánchez-Valle, 2965 of 4601 shared AD–lung cancer genes were reciprocal (64.4%), compared with 361 of 2171 shared AD–glioblastoma genes (16.6%). Forés-Martos reproduced reciprocal predominance, with 1187 of 1992 shared AD–lung cancer genes reciprocal (59.6%). Within the lysosomal panel, reciprocal and concordant changes were intermingled across lysosomal functions. Thirteen of 28 jointly significant genes were reciprocal in Sánchez-Valle (46.4%) and 7 of 11 in Forés-Martos (63.6%), but neither the panel nor individual modules showed reciprocal enrichment beyond genome-wide backgrounds. CTSA, NEU1, ATP6V0E2, and ATP6V1C1 were reproducibly downregulated in AD and upregulated in lung cancer, whereas CTSH showed the opposite pattern; ATP6V1B2, ATP6V1E1, FIG4, and RRAGA were concordantly downregulated. In AD brain, lysosomal differential-expression burden was highest in oligodendrocytes (52.0%) and astrocytes (45.3%), with additional cell-type-specific patterns in microglia and neurons. In matched myeloid populations, 23 of 73 lysosomal genes were directionally matched, including 8 reciprocal and 15 same-direction genes, representing strong enrichment relative to the non-panel background (OR = 7.58, p = 1.11 × 10−11), while reciprocity was not preferentially enriched among directionally matched genes (34.8% vs. 48.6%, p = 0.211). Together, these findings define a heterogeneous lysosomal gene-expression pattern in which broad AD–lung cancer transcriptomic opposition is partitioned across functional programs and cell types, with no evidence for uniform pathway reversal.
Authors
- Eliezer Masliah (ORCID: https://orcid.org/0000-0002-2117-5569)
- Wolf Wrasidlo
Institutions
- University of California San Diego (US)
Publication Details
- Journal
- Cells
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/cells15222101
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00